A Phase 1/2 Clinical Trial to Assess the Safety, Tolerability, Pharmacokinetics and Preliminary Efficacy of HMBD-501 in Patients With HER3-Expressing Solid Tumors

Clinical trial NCT06956690 · RECRUITING

Trial details

NCT number: NCT06956690
Sponsor: Hummingbird Bioscience
Status: RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Melanoma (Skin)Non Small Cell Lung Cancer Breast Cancer

Start date: 2025-12-17
Primary completion: 2027-07-01
Enrollment: 180

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.